»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
½ºÅ¸Æ¾ ½ÃÀåÀº 2024-2029³â¿¡ 30¾ï 8,200¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß CAGRÀº 3.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ºÅ¸Æ¾ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ À¯º´·ü Áõ°¡, ½ÉÇ÷°ü ÁúȯÀÇ À§Çè ¿äÀÎ Áõ°¡, ÀϹÝÀǾàǰ(OTC)¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ¿¬µµ
2025
Á¾·á¿¬µµ
2029
¿¹Ãø ±â°£
2025-2029
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ 2025³â
3.4%
CAGR
3.6%
Áõ°¡¾×
30¾ï 8,200¸¸ ´Þ·¯
º» Á¶»ç´Â ¾÷°èÀÇ ÁÖ¿ä Âü°¡ÀڷκÎÅÍ ÀÎDzÀ» Æ÷ÇÔÇÑ 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸ÀÇ °´°üÀûÀÎ Á¶ÇÕÀ» »ç¿ëÇÏ¿© ½ÃÇàÇß½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â ÁÖ¿ä ±â¾÷ÀÇ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀû ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ ÀÇÇÑ ºÎ¹®, º¥´õ ±¸µµ°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¼ö³â°£ ½ºÅ¸Æ¾ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ³ôÀº ½ÉÇ÷°ü Áúȯ ¹ßº´·üÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚÀÇ °Ç° ÁöÇâÀû ¼ºÇâ°ú ¼±Áø Áö¿ª Àü¹ÝÀÇ ÁÂ½Ä »ýȰ ½À°üÀº ½ÃÀå ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤Å÷ü¡¤±¸ÀÔ ±âÁØÀÇ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°ÈÀÇ ¿äÀÎ
È¥¶õÀÇ ¿äÀÎ
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå ¿¡ÄڽýºÅÛ
½ÃÀåÀÇ Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024
½ÃÀå Àü¸Á 2024-2029
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ½ºÅ¸Æ¾ ½ÃÀå 2019-2023
ÃÖÁ¾»ç¿ëÀÚ ºÎ¹® ºÐ¼® 2019-2023
À¯Çü ºÎ¹® ºÐ¼® 2019-2023
¾à¹° Ŭ·¡½º ºÎ¹® ºÐ¼® 2019-2023
Ä¡·á ¿µ¿ª ºÎ¹® ºÐ¼® 2019-2023
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ ½ºÅ¸Æ¾ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
ÇÕ¼º ½ºÅ¸Æ¾ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
õ¿¬ ½ºÅ¸Æ¾ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : À¯Çüº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ¾àÁ¦ Ŭ·¡½ºº°
½ÃÀå ºÎ¹®
ºñ±³ : ¾àÁ¦ Ŭ·¡½ºº°
Atorvastatin : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Simvastatin : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Pravastatin : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Fluvastatin : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : ¾àÁ¦ Ŭ·¡½ºº°
Á¦11Àå ½ÃÀå ¼¼ºÐÈ : Ä¡·á ¿µ¿ªº°
½ÃÀå ºÎ¹®
ºñ±³ : Ä¡·á ¿µ¿ªº°
½ÉÇ÷°üÁúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ºñ¸¸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿°Áõ¼º Áúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : Ä¡·á ¿µ¿ªº°
Á¦12Àå °í°´ »óȲ
Á¦13Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¸ß½ÃÄÚ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦14Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀåÀÇ ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦15Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°èÀÇ ¸®½ºÅ©
Á¦16Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Abbott Laboratories
Amgen Inc.
AstraZeneca Plc
Aurobindo Pharma Ltd.
Biocon Ltd.
Concord Biotech Ltd.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Thermo Fisher Scientific Inc.
Á¦17Àå ºÎ·Ï
KSA
The statin market is forecasted to grow by USD 3082 mn during 2024-2029, accelerating at a CAGR of 3.6% during the forecast period. The report on the statin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of hypercholesterolemia, increasing risk factors for cardiovascular diseases, and increasing consumer preference for over-the-counter (OTC) drugs.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 3.4%
CAGR 3.6%
Incremental Value $3082 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's statin market is segmented as below:
By End-user
By Type
Synthetic statin
Natural statin
By Drug Class
Atorvastatin
Simvastatin
Pravastatin
Fluvastatin
Others
By Therapeutic Area
Cardiovascular disorders
Obesity
Inflammatory disorders
Others
By Geographical Landscape
North America
Asia
Europe
Rest of World (ROW)
This study identifies the strong incidence of chd as one of the prime reasons driving the statin market growth during the next few years. Also, growing health consciousness among consumers and sedentary lifestyle across the developed regions will lead to sizable demand in the market.
The report on the statin market covers the following areas:
Statin Market sizing
Statin Market forecast
Statin Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading statin market vendors that include Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Biocon Ltd., Concord Biotech Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc.. Also, the statin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Statin Market 2019 - 2023
Historic Market Size - Data Table on Global Statin Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Statin Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by End-user
8.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Clinics - Market size and forecast 2024-2029
Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Chart on Clinics - Year-over-year growth 2024-2029 (%)
Data Table on Clinics - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Synthetic statin - Market size and forecast 2024-2029
Chart on Synthetic statin - Market size and forecast 2024-2029 ($ million)
Data Table on Synthetic statin - Market size and forecast 2024-2029 ($ million)
Chart on Synthetic statin - Year-over-year growth 2024-2029 (%)
Data Table on Synthetic statin - Year-over-year growth 2024-2029 (%)
9.4 Natural statin - Market size and forecast 2024-2029
Chart on Natural statin - Market size and forecast 2024-2029 ($ million)
Data Table on Natural statin - Market size and forecast 2024-2029 ($ million)
Chart on Natural statin - Year-over-year growth 2024-2029 (%)
Data Table on Natural statin - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
10.3 Atorvastatin - Market size and forecast 2024-2029
Chart on Atorvastatin - Market size and forecast 2024-2029 ($ million)
Data Table on Atorvastatin - Market size and forecast 2024-2029 ($ million)
Chart on Atorvastatin - Year-over-year growth 2024-2029 (%)
Data Table on Atorvastatin - Year-over-year growth 2024-2029 (%)
10.4 Simvastatin - Market size and forecast 2024-2029
Chart on Simvastatin - Market size and forecast 2024-2029 ($ million)
Data Table on Simvastatin - Market size and forecast 2024-2029 ($ million)
Chart on Simvastatin - Year-over-year growth 2024-2029 (%)
Data Table on Simvastatin - Year-over-year growth 2024-2029 (%)
10.5 Pravastatin - Market size and forecast 2024-2029
Chart on Pravastatin - Market size and forecast 2024-2029 ($ million)
Data Table on Pravastatin - Market size and forecast 2024-2029 ($ million)
Chart on Pravastatin - Year-over-year growth 2024-2029 (%)
Data Table on Pravastatin - Year-over-year growth 2024-2029 (%)
10.6 Fluvastatin - Market size and forecast 2024-2029
Chart on Fluvastatin - Market size and forecast 2024-2029 ($ million)
Data Table on Fluvastatin - Market size and forecast 2024-2029 ($ million)
Chart on Fluvastatin - Year-over-year growth 2024-2029 (%)
Data Table on Fluvastatin - Year-over-year growth 2024-2029 (%)
10.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
11 Market Segmentation by Therapeutic Area
11.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
11.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
11.3 Cardiovascular disorders - Market size and forecast 2024-2029
Chart on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular disorders - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular disorders - Year-over-year growth 2024-2029 (%)
11.4 Obesity - Market size and forecast 2024-2029
Chart on Obesity - Market size and forecast 2024-2029 ($ million)
Data Table on Obesity - Market size and forecast 2024-2029 ($ million)
Chart on Obesity - Year-over-year growth 2024-2029 (%)
Data Table on Obesity - Year-over-year growth 2024-2029 (%)
11.5 Inflammatory disorders - Market size and forecast 2024-2029
Chart on Inflammatory disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Inflammatory disorders - Market size and forecast 2024-2029 ($ million)
Chart on Inflammatory disorders - Year-over-year growth 2024-2029 (%)
Data Table on Inflammatory disorders - Year-over-year growth 2024-2029 (%)
11.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
11.7 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.5 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.10 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.11 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.12 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.14 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
13.15 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.16 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
16.2 Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
16.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
16.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.7 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
16.8 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
16.9 Concord Biotech Ltd.
Concord Biotech Ltd. - Overview
Concord Biotech Ltd. - Product / Service
Concord Biotech Ltd. - Key offerings
SWOT
16.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.11 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.12 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.13 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
17.5 Data procurement
17.6 Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations